RPA1 and breast neoplasm: Furthermore, McCullough et al. also showed, in 2015, that women with higher levels of RPA (>9.23 h/wk) were more likely to have ER + PR + breast tumours with methylated GSTP1 (OR = 2.33, 95% CI 0.79–6.84) [44].